VCNX — Vaccinex Cashflow Statement
0.000.00%
Last trade - 00:00- $11.25m
- $9.50m
- $0.57m
Annual cashflow statement for Vaccinex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -31.9 | -28.9 | -22.4 | -19.8 | -20.3 |
| Depreciation | |||||
| Non-Cash Items | 0.403 | 0.964 | 0.123 | 0.545 | 2.58 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.496 | -1.07 | -3.21 | -0.011 | 0.318 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -30.7 | -28.6 | -25.3 | -19.1 | -17.2 |
| Capital Expenditures | -0.078 | -0.29 | -0.032 | -0.099 | -0.067 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 14.2 | — | — | — | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 14.1 | -0.29 | -0.032 | -0.099 | -0.067 |
| Financing Cash Flow Items | 13.8 | -0.763 | -0.985 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13.8 | 36.8 | 23.3 | 17 | 12.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.84 | 7.82 | -2.01 | -2.2 | -4.86 |